The unprecedented challenge of pricing a coronavirus vaccine

12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...

Read more →

NICE backs Rozlytrek for subset of NSCLC patients

15 June 2020 - NICE has published final draft guidance backing NHS use of Roche's Rozlytrek (entrectinib) as a treatment ...

Read more →

NICE rejects Sanofi's Cablivi in draft guidelines

12 June 2020 - NICE has drawn up draft guidelines rejecting Sanofi's Cablivi (caplacizumab) for use alongside plasma exchange and immunosuppression ...

Read more →

Tafamidis for treating transthyretin amyloid cardiomyopathy

11 June 2020 - The Department of Health and Social Care has asked the NICE to produce guidance on using tafamidis ...

Read more →

Final NHS green light for Roche's Kadcyla

10 June 2020 - NICE has published final guidance backing NHS use of Roche's Kadcyla (trastuzumab emtansine) for the adjuvant ...

Read more →

UK post-Brexit drug stockpiles at risk amid virus

8 June 2020 - The UK has been warned by the pharmaceutical industry that some stockpiles of medical supplies have ...

Read more →

NICE publishes appraisal consultation for isatuximab in combination with pomalidomide and dexamethasone for treating patients with relapsed and refractory multiple myeloma

 4 June 2020 - The appraisal committee has considered the evidence submitted by the company and the views of non-company consultees ...

Read more →

NICE publishes final guidance backing Teva's Ajovy for migraine

 4 June 2020 - NICE has now published final guidelines endorsing the NHS use of Teva’s Ajovy (fremanezumab) to prevent ...

Read more →

How a US-UK trade agreement could affect NHS drug prices

1 June 2020 - The governments of the UK and US are working on the outlines of a trade agreement. ...

Read more →

COVID-19: UK authorises anti-viral drug remdesivir

26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...

Read more →

NICE issues final guidance on NHS use of Bayer's Vitrakvi

27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...

Read more →

NICE recommends treatment for type of small-cell lung cancer

27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...

Read more →

NICE Chairman Sharmila Nebhrajani begins her new role

26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...

Read more →

Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE

22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...

Read more →

UK bulk buys hydroxychloroquine as potential COVID-19 treatment

20 May 2020 - Hydroxychloroquine is being bought in bulk by the UK in case it does turn out to ...

Read more →